A B S T R A C T
Monosodium glutamate (MSG) is the most widely used additive in the food industry; however, some adverse effects of this additive, including functional, learning, and behavioral alterations, have been observed in experimental animals and humans. Studies have shown learning and memory impairment in adult animals exposed to MSG. However, studies relating exposure to MSG to acetylcholinesterase (AChE) and Na + , K + -ATPase activities and memory damage are still scarce in the literature. The aim of the present study was to assess the possible protective effects of selenofuranoside, an organoselenium compound, against the impairment of longterm memory, Na + , K + -ATPase and AChE activities, and oxidative stress after MSG exposure in rats. MSG (2 g/ kg) and/or selenofuranoside (5 mg/kg) were administered orally to 5-week-old male Wistar rats for 10 days. On the 10th day, after the administration of last dose of the drug(s), the rats were subjected to behavioral tests: the open-field test and step-down passive avoidance task (SDPA). The blood, liver, kidney, cortex, and hippocampus were removed to determine the oxidative stress parameters, such as the levels of reactive species, lipid peroxidation, antioxidant enzyme activities, and endogenous nonenzymatic antioxidant content. Furthermore, the cortex and hippocampus were used to determine the Na + , K + -ATPase and AChE activities. The results demonstrate that the administration of MSG led to long-term memory impairment, as shown in the SDPA task, and also hippocampal and cortical Na + , K + -ATPase inhibition. There were no alterations in the AChE activity and oxidative stress parameters. Treatment with selenofuranoside attenuated memory impairment associated with MSG exposure by improving the hippocampal Na + , K + -ATPase activity.
Introduction
Monosodium glutamate (MSG), the sodium salt of the amino acid Lglutamic acid, has been used for many years as a flavor enhancer, and is generally considered safe [1] . However, neurotoxicity of MSG has been studied following early reports that MSG administration in neonatal mice induced acute neuronal necrosis [2] . Subsequent studies were conducted using different route, and with some differences in dosage and duration, resulting in diverse neurological phenotypes being reported for each regimen [3] [4] [5] . An increase in hippocampal and intracerebral glutamate (Glu) concentrations have been observed after MSG administration, and it has also been reported to significantly alter neurobehavioral performance in rats, causing anxiety and memory impairment [5, 6] . Furthermore, it was demonstrated that the administration of MSG enhanced hippocampal β-amyloid accumulation [7] and significantly impaired short-and long-term memory and recognition memory in rats, which can be attributed to a decrease in plasma and brain tryptophan levels [8] .
It was observed that the administration of MSG can lead to a decrease of Na + , K + -ATPase activity [9, 10] . This enzyme is responsible to maintain the cellular electrochemical gradient and is crucial in the normal cell cycle and differentiation of the nervous system, hence changes in this ATPase activity could have extensive consequences on neuronal function [11] . In fact, it has been demonstrated that the inhibition of Na + , K + -ATPase activity may lead to learning and memory deficits and may also induce apoptosis [12] . Several mechanisms can be related with MSG-induced neurotoxicity, such as the cholinergic system [13] , in which acetylcholinesterase (AChE) plays a major role, as well as the oxidative stress balance and antioxidant system [14, 15] , which includes numerous enzymes. Therefore, substances that could modulate these parameters are a potential therapy to reduce the effect of MSG on the nervous system. Selenium (Se) is an essential trace element in mammals, with several roles in cell growth and functioning. There is currently no evidence for a role of Se in the treatment of AD, but there has been speculation on its potential preventive relevance. In this view, it has been demonstrated that alterations in plasma selenium concentrations and selenoenzymes may play a role in the etiopathogenesis of AD [16, 17] . Selenofuranoside ( Fig. 1) is a novel organic compound of selenium, comprising a simple carbohydrate molecule containing a molecule of Se. Organoselenium compounds have emerged as an important class of therapeutics, with anti-viral, anti-cancer, anti-inflammatory, anti-nociceptive, and neuroprotective activities [18, 19] . A study of our research group has shown the neuroprotective capacity of selenofuranoside in a model of Alzheimer's-like sporadic dementia, induced by an intracerebroventricular injection of Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] in mice [20] .
In this context, considering the neurological and memory damages caused by MSG exposure and the neuroprotective action of selenofuranoside, as mentioned above, the aim of the present study was to assess the effects of selenofuranoside on long-term memory, oxidative stress, biochemical parameters, and Na + , K + -ATPase and AChE activities after the administration of MSG in rats.
Material and methods

Chemicals
MSG, ascorbic acid, and 2′,7′-dichlorodihydrofluorescein diacetate (DCHF-DA) were purchased from Sigma-Aldrich (St. Louis, MO, USA). All other reagents used were of analytical grade and were obtained locally. Selenofuranoside (Fig. 1) was synthesized according to the method used by Braga et al. [21] .
Animals
The experiments were conducted using 5-week-old male Wistar rats (110-140 g). The rats were obtained from the Federal University of Santa Maria (Santa Maria, Brazil). The rats were kept in a chamber with forced air ventilation, under a 12-h light/dark cycle, at a controlled room temperature of 22 ± 2°C, with food (Puro Trato, RS, Brazil) and water provided ad libitum. The procedures in this study were performed according to the guidelines of the Committee on the Care and Use of Experimental Animals, and this study was approved by the Ethics Committee on the Use of Animals of the Federal University of Pampa (Uruguaiana, Brazil) (Protocol no. 022/2015).
Experimental procedure
The 5-week-old rats were randomly assigned to one of four groups. Each group contained six rats, which were subjected to the assigned treatment for 10 days (Fig. 2) . The dose and route of administration of MSG were based on those in the study by Dief et al. [7] , and the dose of selenofuranoside was based on that in the study by Spiazzi et al. [20] .
Group 1 (Control): saline (gavage) + vehicle (canola oil) (gavage). Group 2 (MSG): MSG (2 g/kg, gavage) + vehicle (canola oil) (gavage).
Group 3 (Se): saline (gavage) + selenofuranoside (5 mg/kg, gavage).
Group 4 (MSG + Se): MSG (2 g/kg, gavage) + selenofuranoside (5 mg/kg, gavage).
In groups 3 and 4, selenofuranoside was administered daily, 1 h after the administration of MSG, and both were administered orally. At the end of 10 days of treatment, all groups were subjected to behavioral tests, as described below. The rats were fasted for 12 h and killed by terminal anesthesia. Blood samples were collected by cardiac puncture, and the kidney and liver tissues were quickly extracted and homogenized in 50 mM Tris-HCl (pH 7.4; 1/10, w/v). The homogenate was centrifuged at 2400 rpm for 15 min, and the low-speed supernatant fraction (S1) was used for the assays. The brain was extracted through a craniotomy, and the whole hippocampus and cortex were dissected on an ice-cold plate and stored at − 80°C until neurochemical assays.
Behavioral procedure
Open-field test (OFT)
Spontaneous locomotor activity was measured on the 10th day using the OFT: the dimensions of the open field were 60 cm × 50 cm × 50 cm, and it was built with polyvinyl chloride plastic, plywood, and transparent acrylic, with the floor divided into 12 equal squares [22] . Each animal was placed individually at the center of the arena, and line crossing (four-paw criterion) and rearing (two-paw criterion) over a 5-min session were measured. This test was carried out to identify motor disabilities, which could influence step-down passive avoidance (SDPA) performance during the SDPA task.
Step-down passive avoidance task
Nonspatial long-term memory was measured using the SDPA task. The rats were subjected to one training session for the SDPA task, as described previously [23] . During training, the rats were gently placed on the platform of the apparatus facing the rear left corner, and when 
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Physiology & Behavior 184 (2018) [27] [28] [29] [30] [31] [32] [33] they stepped down and placed their four paws on the grid floor, an electric shock (0.5 mA) was delivered for 2 s. This procedure was repeated two more times (for a maximum of three shocks) or until the animal remained on the platform for 1 min. The long-term memory test was performed 24 h after the training; each animal was placed again on the platform and the step-down latency was measured, considering a cutoff time of 300 s. The SDPA task was performed on the 11th and 12th days of the experimental protocol.
Biochemical analysis
The dosages of triglycerides, total cholesterol, high-density lipoprotein (HDL) cholesterol, blood glucose, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were measured using commercial kits (Labtest Diagnostica, MG, Brazil). The LDL cholesterol levels were estimated using the Friedewald equation [24] , and are expressed as mg/dl.
Measurement of intracellular reactive oxygen species (ROS) production
The ROS levels were determined using the DCHF-DA assay, which is a spectrofluorometric method [25] . S1 was incubated with 10 μl of DCHF-DA (1 mM), and the oxidation of DCHF-DA to fluorescent dichlorofluorescein was measured on the basis of the fluorescence emission intensity at 520 nm (with 488 nm excitation) 30 min after the addition of DCHF-DA to the medium. The results are expressed as FU.
Catalase (CAT) activity
CAT activity was spectrophotometrically determined according to the method of Aebi [26] . The assay involves monitoring the consumption of H 2 O 2 in the presence of the sample (S1) (20 μl) at 240 nm. One unit of enzyme was defined as the amount of enzyme required to monitor the disappearance of H 2 O 2 . Enzymatic activity was expressed as U/mg protein (1 U decomposes 1 μmol H 2 O 2 /min at pH 7 and 25°C).
Superoxide dismutase (SOD) activity
SOD activity was determined using the method described by Misra and Fridovich [27] . This method is based on the ability of SOD to inhibit the autoxidation of epinephrine to adrenochrome. The enzymatic reaction was initiated by the addition of an aliquot (20-60 μl) of S1 and the substrate (epinephrine), in a concentration of 60 mM, to a medium containing 50 mM glycine buffer (pH 10.3). The reaction can be monitored at 480 nm. One unit of enzyme was defined as the amount of enzyme required for 50% inhibition of the epinephrine autoxidation rate at 30°C. Results are expressed as UI.
Thiobarbituric acid reactive substances (TBARS) measurement
The amount of TBARS was determined as described by Ohkawa et al. [28] , i.e., by measuring the concentration of malondialdehyde (MDA) formed as an end product of lipid peroxidation by the reaction with thiobarbituric acid. The tissues were homogenized, and an aliquot (100 μl) of S1 was incubated at 95°C for 2 h. The results are expressed as nmol MDA/mg protein.
Ferric reducing antioxidant potential (FRAP)
The FRAP assay was performed according to the method used by Benzie and Strain [29] . This assay is based on the capacity of ferric ions to reduce to ferrous ions at a low pH, resulting in the formation of a colored ferrous-tripyridyltriazine complex. Colorimetric measurements were performed at 593 nm. A standard curve of ascorbic acid was used, and the results are expressed as μg equivalents of ascorbic acid. 
and centrifuged at 2500 rpm for 10 min to yield a low-speed supernatant fraction (S1). The reaction mixture for the assay of Na + , K + -ATPase activity contained 3 mM MgCl 2 , 125 mM NaCl, 20 mM KCl, 50 mM Tris-HCl (pH 7.5), and distilled water. An aliquot containing 50 μl of S1 and 10 μl of dimethyl sulfoxide was added to the reaction mixture, and it was preincubated at 37°C for 10 min. The reaction was initiated by the addition of 50 μl of ATP (30 mM) to a final concentration of 3.0 mM, and the reaction mixture was incubated at 37°C for 30 min. Control assays were carried out under the same conditions, with the addition of 10 μl of 0.1 mM ouabain. The reaction was stopped by adding 250 μl of trichloroacetic acid solution (10%) with 10 mM HgCl 2 . The Na + , K + -ATPase activity was calculated from the difference between the two assays (with and without ouabain). The release of inorganic phosphate (Pi) was measured using the method of Fiske [31] . The results are expressed as nmol Pi/mg protein/min.
Acetylcholinesterase
The activity of AChE was measured in a 96-well microtiter plate according to the method of Ellman et al. [32] , using acetylthiocholine (AcSCh) as the substrate. The reaction mixture contained 100 mM K + -phosphate buffer (pH 7.5) and 1 mM 5,5′-dithiobisnitrobenzoic acid. This method is based on the formation of the yellow anion 5,5′-dithiobisnitrobenzoate over 2 min of incubation at 25°C, whose levels were measured on the basis of the absorbance at 412 nm. The enzyme (40-50 μg of protein) was preincubated for 2 min. The activity of AChE is expressed as μmol AcSCh/h/mg protein.
Protein determination
Protein determination was carried out using the Coomassie blue method described by Bradford [33] , with bovine serum albumin as the standard.
Statistical analysis
Statistical analysis was performed using one-way analysis of variance (ANOVA), followed by Tukey's test when necessary. p < 0.05 was considered statistically significant. Data are expressed as mean ± standard deviation.
Results
Open-field test
The OFT was used to eliminate the nonspecific effects of the treatments in the behavioral test. Neither MSG nor Se treatment altered the number of line crossings and rearings in the rats (Table 1) .
Step-down passive-avoidance task
During the training session on passive avoidance, there was no difference in the step-down latency time to first fall among the groups (Fig. 3A) . MSG significantly decreased the step-down latency time in the long-term memory test session, whereas Se protected against this alteration (Se × MSG interaction; F (1,38) = 8.087, p = 0.0071) [27] [28] [29] [30] [31] [32] [33] ( Fig. 3B ).
Biochemical analysis
The results show that the MSG and MSG + Se groups had a significantly reduced total cholesterol level compared to that of the control group (Table 2) . A decrease in the HDL levels in the rats from the MSG and Se groups and in the LDL cholesterol levels in those of the MSG + Se group were also observed. Furthermore, the results revealed that MSG and its association with selenofuranoside did not alter the ALT and AST levels and other liver parameters, which suggests the absence of peripheral toxicity (Table 2) .
Reactive species, catalase, superoxide dismutase, thiobarbituric acid reactive substances, and ferric reducing antioxidant potential
There were no statistically significant differences in the RS, TBARS, CAT, SOD, and FRAP levels in the liver and kidney of rats exposed to MSG, as shown in Tables 3 and 4 . This reinforces the hypothesis that MSG did not cause peripheral toxicity. In the hippocampus, an increase in SOD in the selenofuranoside group and a decrease in FRAP in the MSG + Se group (Table 5) were observed; however, no changes were observed in the cortex (Table 6 ).
Na + , K + -ATPase activity
The administration of MSG caused a significant decrease in the Na + , K + -ATPase activity in the hippocampus and cortex compared to that in the control group. Selenofuranoside therapy was able to prevent this decrease in the hippocampus (Se × MSG interaction; F (1,21) = 12.78, p = 0.0018) (Fig. 4A) but not in the cortex (Fig. 4B ).
Acetylcholinesterase
Results obtained on the AChE activity in the hippocampus and cortex are presented in Fig. 5 . Exposure to MSG did not cause alterations in the AChE activity.
Discussion
The results of the present study revealed that therapy with selenofuranoside protected against memory impairment through an increase in the Na + , K + -ATPase activity in the hippocampus of rats exposed to MSG. We observed a significant decrease in the step-down latency of rats exposed to MSG, suggesting long-term memory impairment in these animals. Narayanan et al. [6] and Khaliq et al. [8] reported similar results in the behavioral tests of animals exposed to MSG. Moreover, Khaliq et al. [8] evaluated the adverse effects of exposure to MSG on memory functions, and their results showed that MSG administration significantly impaired recognition memory and short-and long-term memory in the water maze. Dief et al. [7] showed that treatment with MSG induced neurobehavioral abnormalities consistent with hippocampal damage. In our study, selenofuranoside was effective in ameliorating the memory impairment observed in animals exposed to MSG, providing additional evidence for the protective effect of this compound, as it improved the rats' performance in the memory task. Spiazzi et al. [20] found similar results, according to which selenofuranoside was effective in increasing the latency in the SDPA task in a model of Alzheimer-like sporadic dementia. These findings are in agreement with those reported previously, validating the fact that organic Se compounds are effective in preventing, improving, or ameliorating memory damage in rodents [34, 35] . In the SDPA protocol used in this study, long-term aversive memory, that is, consolidated memory 24 h after an episode, was assessed. Several studies have reported a complex involvement of the hippocampus in long-term aversive memory [36, 37] , and that hippocampal neurogenesis modulates aversive memory in adults [38] . Results were expressed as mg/dl. Data are reported as means ± S.D. (n = 6). ⁎ p < 0.05 as compared to the control group.
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Further, aversive memory associated with the inhibitory avoidance task in rats is involved in the activation of Glu receptors, increase in intracellular Ca 2 + levels, and activation of signaling pathways that result in the synthesis of new proteins [39] . Thus, we suggest that selenofuranoside ameliorates memory impairment in this model by directly or indirectly modulating the glutamatergic system. Organoselenium compounds are well known for their interaction with the glutamatergic system [40] . They modulate Glu neurotransmission, protecting neuronal cells from injuries induced by Glu [41] . Aiming at providing more information related to memory impairment and selenofuranoside intervention, the Na + , K + -ATPase and AChE activities were assessed. No differences were observed in the AChE activity in our study; however, our results demonstrated that MSG exposure caused a significant decreased in the Na + , K + -ATPase activity in the hippocampus and cortex. An important finding of our study is that the inhibition of Na + , K + -ATPase activity in the hippocampus is reversed by selenofuranoside, which is in agreement with the memory improvement, as observed in the SDPA task. Thus, we can suggest that the inhibition of hippocampal Na + , K + -ATPase activity is partially responsible for the behavioral effect identified in the long-term memory test session of the SDPA task. These findings are in agreement with others studies, in which another organoselenium compound was demonstrated to have the ability to restore Na
ATPase activity in MSG-treated rats [9, 10] . Previous studies have demonstrated that inhibition of Na + , K + -ATPase activity can impair learning and memory in the SDPA task, and this is found in various neuropathological conditions that are possibly associated with excitotoxic mechanisms [42, 43] . Na + , K + -ATPase and sodium-dependent Glu transporters (GluTs) are closely linked in brain tissue; they are a part of the same macromolecular complexes and operate as a functional unit to regulate glutamatergic neurotransmission [44] . According to Zhang et al. [45] , inhibition of this ATPase can restrict Glu absorption [27] [28] [29] [30] [31] [32] [33] by inhibiting the activity of GluTs, and inversely, extracellular Glu stimulates Na + , K + -ATPase via GluTs activation. Thus, Na + , K + -ATPase is an important modulator of Glu uptake because of its potential to regulate GluTs, making it a potential target for protection against neurotoxicity induced by Glu.
The inhibition of cortical Na + , K + -ATPase activity could not be directly related to memory impairment of the conditioned fear induced by MSG, as observed in our work, as fear memory is more strongly associated with the hippocampus. However, this inhibition may be associated with losses in other types of memory, such as working memory, which has been demonstrated by Khaliq et al. [8] . MSG has been investigated in mice and rats using different experimental protocols that employ a wide range of dosing regimens and routes of administration (including intraperitoneal, subcutaneous, and peroral) [6, 7, 15] . Thus, studies using MSG in similar doses but with different routes of administration exhibited different results [6, 14] . In studies on animals of a similar age group exposed to MSG, increased levels of oxidative stress parameters were observed [14, 15] , which was not observed in our study. Moreover, the administration of selenofuranoside and MSG did not alter AChE activity in the cerebral tissues of rats. Contini et al. [46] did not observe increased lipid peroxidation either, as the SOD and CAT activities remained unchanged in the kidneys of 5-week-old rats receiving MSG as part of their standard diet for 16 weeks. It is difficult to explain why the parameters of oxidative stress and AChE activity remained unchanged upon MSG exposure. It is suggested that the differences in the routes of administration, doses of MSG, and periods of exposure can explain the differences in the results for these parameters, as well as for the biochemical parameters evaluated in our study, in MSG-exposed animals. These results clearly reveal that oxidative stress is not related to memory damage induced by MSG.
In addition, we studied whether acute administration of MSG also affects biochemical parameters. Our results did not show an increase in the biochemical parameters evaluated, such as that demonstrated by other studies that have suggested a possible link between MSG and overweight/obesity and metabolic syndrome [2, 47] . In contrast, our results showed a significant reduction in the total cholesterol levels, with additional specific changes in the HDL or LDL level. We cannot determine the exact reason for this; however, we believe that the variability in the MSG administration protocols might be responsible for the different results obtained.
Conclusion
We showed that the administration of MSG causes impairment of memory, as presented in the SDPA task, through a decrease in the Na + , K + -ATPase activity, and that selenofuranoside can serve as a novel therapeutic to ameliorate this effect. Moreover, our results suggest that the restoration of Na + , K + -ATPase activity is, at least in part, involved in the beneficial effects of selenofuranoside against MSG-induced memory impairment. Further studies are necessary to clarify the mechanisms underlying selenofuranoside protection and its relevance as an adjuvant therapy for memory deficits. [27] [28] [29] [30] [31] [32] [33] 
